Chestny ZNAK mandates that every pharmaceutical product bear a unique 2D Data Matrix code containing critical identifiers including the Global Trade Item Number (GTIN), randomized serial number, batch information, expiration date, and FEACN code. Most notably, each code incorporates a 44-character cryptographic security element, creating a sophisticated digital passport that accompanies products throughout their lifecycle.

The system creates complete visibility from production to point-of-sale through mandatory reporting at each transfer of ownership. The Center for Research in Perspective Technologies (CRPT) issues unique codes to manufacturers or importers, with all subsequent movements tracked in the Federal State Information System for Monitoring Drug Circulation (FSISMDC). This comprehensive approach enables real-time monitoring of pharmaceutical products and swift identification of irregularities.

When medicines reach pharmacies, hospitals, or clinics, they must be scanned and registered in the Chestny ZNAK system prior to dispensing. The point-of-sale scanning process effectively decommissions the product from circulation, preventing unauthorized resale or substitution with counterfeit products. This verification mechanism extends to consumers, who can authenticate products using the Chestny ZNAK mobile application.

Russia has established a rigid compliance framework with substantial consequences for violations. Non-adherence to Chestny ZNAK requirements can result in market exclusion, significant financial penalties, and even imprisonment under certain circumstances. This enforcement mechanism underscores Russia's commitment to pharmaceutical security and patient safety.